Quick Answer
KalVista Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 49.76 million shares for the year ending 2025.
- KalVista Pharmaceuticals, Inc. showed an increase of +17.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from KalVista Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 10, 2025.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), KalVista Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has grown by 7,098.2%.
- Historical annual values: Fiscal year 2025: 49.76 million shares | Fiscal year 2024: 42.52 million shares | Fiscal year 2023: 34.17 million shares | Fiscal year 2022: 24.55 million shares | Fiscal year 2021: 24.42 million shares | Fiscal year 2020: 17.85 million shares | Fiscal year 2019: 17.28 million shares | Fiscal year 2018: 10.80 million shares | Fiscal year 2017: 9.71 million shares | Fiscal year 2016: 0 shares | Fiscal year 2015: 26.32 million shares | Fiscal year 2014: 691,312 shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: